Jump to main content
Jump to site search


Synthesis, and biological evaluation of novel asymmetric naphthalene diimide derivative as anticancer agent depending on ROS generation

Abstract

Naphthalenetetracarboxylic diimide (NDI) is widely used as a photoelectric material in the field of medicine. A series of asymmetric naphthalene diimide derivatives were synthesized and evaluated for their anticancer properties by various experimental assays. As the representative compound, 3c exerted significant greater inhibitory effects on hepatoma cells SMMC-7721 and Hep G2 with IC50 value of 1.48±0.43 µM and 1.70±0.53 µM, respectively, than normal hepatocyte QSG-7701 with IC50 value of 7.11±0.08 µM. Treatment of compound 3c (3 μM) for 48 h resulted in apoptosis of SMMC-7721 cells and Hep G2 cells with 52.1% and 67.8% apoptotic cells, respectively. Compund 3c induced autophagy, and suppressed migration of hepatoma cells in a concentration-dependent manner, resulting from the generation of reactive oxygen species (ROS). Based on its biological ability, compound 3c was considered as a potent anticancer agent.

Back to tab navigation

Supplementary files

Publication details

The article was received on 22 May 2018, accepted on 05 Jul 2018 and first published on 06 Jul 2018


Article type: Research Article
DOI: 10.1039/C8MD00265G
Citation: Med. Chem. Commun., 2018, Accepted Manuscript
  •   Request permissions

    Synthesis, and biological evaluation of novel asymmetric naphthalene diimide derivative as anticancer agent depending on ROS generation

    X. Xu, S. Wang, Y. Chang, C. Ge, X. Li, Y. Feng, S. Xie, C. Wang, F. Dai and W. Luo, Med. Chem. Commun., 2018, Accepted Manuscript , DOI: 10.1039/C8MD00265G

Search articles by author

Spotlight

Advertisements